当前位置:首页 - 行情中心 - 澳洋健康(002172) - 财务分析 - 现金流量表

澳洋健康

(002172)

  

流通市值:45.22亿  总市值:45.25亿
流通股本:7.65亿   总股本:7.66亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金826,128,899.42579,190,484.36261,832,123.11,733,661,841.4
  收到的税费返还00--
  收到其他与经营活动有关的现金86,790,450.4371,092,321.17117,080,138.07197,483,825.67
  经营活动现金流入小计912,919,349.85650,282,805.53378,912,261.171,931,145,667.07
  购买商品、接受劳务支付的现金585,141,176.71437,808,536.13182,888,244.41,327,720,345.48
  支付给职工以及为职工支付的现金226,368,270.77153,861,860.8286,665,281.88306,806,155.78
  支付的各项税费25,689,905.1216,609,023.188,909,610.8150,760,741.58
  支付其他与经营活动有关的现金157,538,483.9291,773,481.9868,614,046.04233,238,039.95
  经营活动现金流出小计994,737,836.52700,052,902.11347,077,183.131,918,525,282.79
  经营活动产生的现金流量净额-81,818,486.67-49,770,096.5831,835,078.0412,620,384.28
二、投资活动产生的现金流量:
  收回投资收到的现金0---
  处置固定资产、无形资产和其他长期资产收回的现金净额64,330.7364,330.731,066.18252,358.23
  投资活动现金流入小计64,330.7364,330.731,066.18252,358.23
  购建固定资产、无形资产和其他长期资产支付的现金12,963,233.919,376,100.655,003,935.9332,581,209.48
  投资支付的现金---300,000
  支付其他与投资活动有关的现金---10,760,566.52
  投资活动现金流出小计12,963,233.919,376,100.655,003,935.9343,641,776
  投资活动产生的现金流量净额-12,898,903.18-9,311,769.92-5,002,869.75-43,389,417.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,5009,5009,500330,000
  其中:子公司吸收少数股东投资收到的现金9,5009,5009,500330,000
  取得借款收到的现金935,168,000763,825,000539,095,523.181,141,610,962.66
  收到其他与筹资活动有关的现金33,600,00013,600,00013,600,00088,040,000
  筹资活动现金流入小计968,777,500777,434,500552,705,023.181,229,980,962.66
  偿还债务支付的现金752,438,094.83584,895,750.38490,805,944.461,129,151,737.11
  分配股利、利润或偿付利息支付的现金18,054,804.5613,046,430.18,255,257.4529,610,441.1
  其中:子公司支付给少数股东的股利、利润00-1,125,000
  支付其他与筹资活动有关的现金126,703,631.33129,693,333.62126,446,794.6146,581,010.58
  筹资活动现金流出小计897,196,530.72727,635,514.1625,507,996.511,305,343,188.79
  筹资活动产生的现金流量净额71,580,969.2849,798,985.9-72,802,973.33-75,362,226.13
四、汇率变动对现金及现金等价物的影响-12,950.95-9,607.93-15,027.83-21,923.16
五、现金及现金等价物净增加额-23,149,371.52-9,292,488.53-45,985,792.87-106,153,182.78
  加:期初现金及现金等价物余额159,913,611.36159,913,611.36159,913,611.36266,066,794.14
  期末现金及现金等价物余额136,764,239.84150,621,122.83113,927,818.49159,913,611.36
补充资料:
  净利润-24,145,664.85-41,884,746.38
  资产减值准备--1,267,841.54-16,374,462.44
  固定资产和投资性房地产折旧-24,962,173.87-50,461,536.07
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-24,962,173.87-50,461,536.07
  无形资产摊销-2,183,761.5-4,335,422.75
  长期待摊费用摊销-418,523.24-1,637,814.88
  处置固定资产、无形资产和其他长期资产的损失--20,441.06--6,876.33
  固定资产报废损失-14,842.84-312,494.18
  公允价值变动损失---300,000
  财务费用-13,290,717.14-29,567,043.36
  投资损失-427,315.67--2,154,386.5
  递延所得税-767,073.08--1,762,484.61
  其中:递延所得税资产减少-752,153.65--1,850,272.38
    递延所得税负债增加-14,919.43-87,787.77
  存货的减少-10,128,112.92-15,792,638.14
  经营性应收项目的减少--84,890,955.54--520,644,201.87
  经营性应付项目的增加--41,084,994.36-369,139,303.32
  现金的期末余额-150,621,122.83-159,913,611.36
  减:现金的期初余额-159,913,611.36-266,066,794.14
  现金及现金等价物的净增加额--9,292,488.53--106,153,182.78
公告日期2026-10-232026-08-182026-04-302026-03-31
审计意见(境内)标准无保留意见
TOP↑